Skip to content
My WebMD Sign In, Sign Up

Bladder Cancer Health Center

Medical Reference Related to Bladder Cancer

  1. Bladder Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - nci_ncicdr0000062908-nci-header

    This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Bladder Cancer Treatment

  2. Urethral Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - About This PDQ Summary

    PURPOSE OF THIS SUMMARY This PDQ cancer information summary for health professionals provides comprehensive,peer-reviewed,evidence-based information about the treatment of urethral cancer. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions. REVIEWERS AND UPDATES ...

  3. Bladder Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Cellular Classification of Bladder Cancer

    More than 90% of bladder carcinomas are transitional cell carcinomas derived from the uroepithelium. About 6% to 8% are squamous cell carcinomas,and 2% are adenocarcinomas.[ 1 ] Adenocarcinomas may be either of urachal origin or of nonurachal origin; the latter type is generally thought to arise from metaplasia of chronically irritated transitional epithelium.[ 2 ] Pathologic grade,which is ...

  4. Urethral Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Changes to This Summary (10 / 05 / 2012)

    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above. This summary was comprehensively reviewed and extensively revised.This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.

  5. Bladder and Other Urothelial Cancers Screening (PDQ®): Screening - Health Professional Information [NCI] - Questions or Comments About This Summary

    If you have questions or comments about this summary,please send them to Cancer.gov through the Web site’s Contact Form. We can respond only to email messages written in English. ...

  6. Bladder Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage I Bladder Cancer

    Note: Some citations in the text of this section are followed by a level of evidence. The PDQ editorial boards use a formal ranking system to help the reader judge the strength of evidence linked to the reported results of a therapeutic strategy. (Refer to the PDQ summary on Levels of Evidence for more information.) Stage I bladder cancer is defined by the following TNM classification: T1,N0,...

  7. Urethral Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Distal Urethral Cancer

    Female Distal Urethral CancerIf the malignancy is at or just within the meatus and superficial parameters (stage 0/Tis, Ta), open excision or electroresection and fulguration may be possible. Tumor destruction using Nd:YAG or CO2 laser vaporization-coagulation represents an alternative option. For large lesions and more invasive lesions (stage A and stage B, T1 and T2, respectively), brachytherapy or a combination of brachytherapy and external-beam radiation therapy are alternatives to surgical resection of the distal third of the urethra. Patients with T3 distal urethral lesions, or lesions that recur after treatment with local excision or radiation therapy, require anterior exenteration and urinary diversion. If inguinal nodes are palpable, frozen section confirmation of tumor should be obtained. If positive for malignancy, ipsilateral node dissection is indicated. If no inguinal adenopathy exists, node dissection is not generally performed, and the nodes are followed clinically.

  8. Bladder Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Options for Recurrent Bladder Cancer

    Treatment of recurrent bladder cancer depends on previous treatment and where the cancer has recurred. Treatment for recurrent bladder cancer may include the following: Surgery. Chemotherapy. Radiation therapy. A clinical trial of chemotherapy. This summary section refers to specific treatments under study in clinical trials,but it may not mention every new treatment being studied. ...

  9. Bladder Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Changes to This Summary (03 / 04 / 2013)

    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above. Editorial changes were made to this summary.

  10. Bladder Cancer - Exams and Tests

    To determine whether bladder cancer may be the cause of your urinary symptoms, your health professional will evaluate you.

Displaying 41 - 50 of 68 Articles << Prev Page 1 2 3 4 5 6 7 Next >>

Today on WebMD

Integrative Medicine Cancer Quiz
QUIZ
what is your cancer risk
HEALTH CHECK
 
cancer fighting foods
SLIDESHOW
Bladder Cancer Why More Men May Be At Risk
VIDEO
 
Lifestyle Tips for Depression Slideshow
SLIDESHOW
Bladder Sparing Cancer Treatment
VIDEO
 
Vitamin D
SLIDESHOW
Pets Improve Your Health
SLIDESHOW
 

WebMD Special Sections